GGrantIndex
← Leaderboards

Jose Aron Lopez

Baylor College Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗
$21,118,772
Attributed
$24,881,195
Total exposure
17
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$30,448,865 · 18

By mechanism

R01$16,311,871 · 7
R35$7,764,252 · 2
P50$5,779,667 · 2
R21$487,863 · 1
P41$100,212 · 5
R13$5,000 · 1

Top collaborators

Most similar at Baylor College Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Von Willebrand Factor”

Research focus

Von Willebrand FactorBlood PlateletsPlasmaThrombosisMutantGlycoproteinsPlasma ProteinsAffectVon Willebrand DiseaseAcetylcysteineAmino AcidsStructureMutationBloodProteolysisLifeMetalloproteasesBaseErythrocytesSickle Cell AnemiaHemorrhagePharmaceutical PreparationsHuman SubjectMember

Grant awards (52)

Molecular and Translational Studies in Hematologic Disorders$1,276,908
R35 · FY2025 · HL · contact PI
Role of sialoglycan binding in the pathogenesis of streptococcal endocarditis$793,615
R01 · FY2025 · AI
Molecular and Translational Studies in Hematologic Disorders$1,052,245
R35 · FY2024 · HL · contact PI
Role of sialoglycan binding in the pathogenesis of streptococcal endocarditis$816,903
R01 · FY2024 · AI
Molecular and Translational Studies in Hematologic Disorders$1,080,109
R35 · FY2023 · HL · contact PI
Role of sialoglycan binding in the pathogenesis of streptococcal endocarditis$806,682
R01 · FY2023 · AI
Molecular and Translational Studies in Hematologic Disorders$1,081,020
R35 · FY2022 · HL · contact PI
Molecular and Translational Studies in Hematologic Disorders$1,083,722
R35 · FY2021 · HL · contact PI
Molecular and Translational Studies in Hematologic Disorders$1,084,583
R35 · FY2020 · HL · contact PI
Molecular and Translational Studies in Hematologic Disorders$1,105,665
R35 · FY2019 · HL · contact PI
von Willebrand Factor in Sickle Cell Disease Pathophysiology$732,180
R01 · FY2018 · HL · contact PI
von Willebrand Factor in Sickle Cell Disease Pathophysiology$732,180
R01 · FY2017 · HL · contact PI
Biosynthetic and Functional Consequences of von Willebrand Disease Mutations$579,456
R01 · FY2017 · HL · contact PI
von Willebrand Factor in Sickle Cell Disease Pathophysiology$729,091
R01 · FY2016 · HL · contact PI
Biosynthetic and Functional Consequences of von Willebrand Disease Mutations$579,456
R01 · FY2016 · HL · contact PI
Endothelial Activation and Microangiopathy in HIV-related Cardiovascular Disease$215,207
R21 · FY2016 · HL
von Willebrand Factor in Sickle Cell Disease Pathophysiology$148,808
R01 · FY2016 · HL · contact PI
von Willebrand Factor in Sickle Cell Disease Pathophysiology$718,154
R01 · FY2015 · HL · contact PI
Biosynthetic and Functional Consequences of von Willebrand Disease Mutations$570,764
R01 · FY2015 · HL · contact PI
Endothelial Activation and Microangiopathy in HIV-related Cardiovascular Disease$272,656
R21 · FY2015 · HL
von Willebrand Factor in Sickle Cell Disease Pathophysiology$731,326
R01 · FY2014 · HL · contact PI
Biosynthetic and Functional Consequences of von Willebrand Disease Mutations$571,336
R01 · FY2014 · HL · contact PI
von Willebrand Factor in Sickle Cell Disease Pathophysiology$710,432
R01 · FY2013 · HL · contact PI
Biosynthetic and Functional Consequences of von Willebrand Disease Mutations$619,415
R01 · FY2013 · HL · contact PI
von Willebrand Factor in Sickle Cell Disease Pathophysiology$776,238
R01 · FY2012 · HL · contact PI
Regulation of von Willebrand Factor Reactivity$465,869
R01 · FY2012 · HL · contact PI
Regulation of von Willebrand Factor Reactivity$465,869
R01 · FY2011 · HL · contact PI
Regulation of von Willebrand Factor Reactivity$470,575
R01 · FY2010 · HL · contact PI
Regulation of von Willebrand Factor Reactivity$503,930
R01 · FY2009 · HL · contact PI
PLATELET TOMOGRAPHY$8,699
P41 · FY2009 · RR · contact PI
PLATELET TOMOGRAPHY$32,462
P41 · FY2008 · RR · contact PI
PLATELET TOMOGRAPHY$16,289
P41 · FY2007 · RR · contact PI
PLATELET TOMOGRAPHY$15,059
P41 · FY2006 · RR · contact PI
2006 Gordon Research Conference on Hemostasis$5,000
R13 · FY2006 · HL · contact PI
PLATELET TOMOGRAPHY$27,703
P41 · FY2005 · RR
PLATELET, SHEAR STRESS, AND ARTERIAL THROMBOSIS$1,434,821
P50 · FY2004 · HL
PLATELET INTERACTIONS WITH ENDOTHELIUM AND LEUKOCYTES$373,750
R01 · FY2004 · HL
ADHESION RECEPTOR POLYMORPHISMS: FUNCTIONAL STUDIES$336,375
R01 · FY2004 · HL
PLATELET, SHEAR STRESS, AND ARTERIAL THROMBOSIS$1,410,593
P50 · FY2003 · HL
PLATELET INTERACTIONS WITH ENDOTHELIUM AND LEUKOCYTES$373,750
R01 · FY2003 · HL
ADHESION RECEPTOR POLYMORPHISMS: FUNCTIONAL STUDIES$336,375
R01 · FY2003 · HL
PLATELET, SHEAR STRESS, AND ARTERIAL THROMBOSIS$1,369,565
P50 · FY2002 · HL
PLATELET INTERACTIONS WITH ENDOTHELIUM AND LEUKOCYTES$373,750
R01 · FY2002 · HL
ADHESION RECEPTOR POLYMORPHISMS: FUNCTIONAL STUDIES$336,375
R01 · FY2002 · HL
Molecular determinants of glycoprotein Ib/vonWillibrand factor interaction$211,997
P50 · FY2002 · HL
PLATELET, SHEAR STRESS, AND ARTERIAL THROMBOSIS$1,352,691
P50 · FY2001 · HL
PLATELET INTERACTIONS WITH ENDOTHELIUM AND LEUKOCYTES$373,750
R01 · FY2001 · HL
ADHESION RECEPTOR POLYMORPHISMS: FUNCTIONAL STUDIES$336,375
R01 · FY2001 · HL
Molecular determinants of glycoprotein Ib/vonWillibrand factor interaction$0
P50 · FY2001 · HL
PLATELET INTERACTIONS WITH ENDOTHELIUM AND LEUKOCYTES$373,125
R01 · FY2000 · HL
ADHESION RECEPTOR POLYMORPHISMS: FUNCTIONAL STUDIES$336,375
R01 · FY2000 · HL
MOLECULAR GENETICS OF HUMAN PLATELET GLYCOPROTEINS$239,592
R01 · FY2000 · HL